WallStSmart
AVXL

Anavex Life Sciences Corp

NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY

$3.34
+2.45% today

Updated 2026-04-30

Market cap
$309.52M
P/E ratio
P/S ratio
EPS (TTM)
$-0.46
Dividend yield
52W range
$3 – $14
Volume
1.4M

Anavex Life Sciences Corp (AVXL) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-32428.00$-325250.00$-2.47M$-2.79M$-4.59M$-3.80M$-1.69M$-777573.00$-2.66M$-4.23M$-9.24M$-9.02M$-12.58M$-18.53M$-21.29M$-30.38M$-24.24M$-27.79M$-30.81M$-39.04M
Capital expenditures$0.00$0.00$1082.00$1239.00$3310.00$0.00$0.00$0.00$3015.00$0.00$3015.00$0.00$0.00$0.00$4.00$4.00$4.00$0.00$0.00$0.00
Depreciation
Stock-based comp$1.68M$812336.00$770055.00$1.27M$302208.00$1.00M$637925.00$1.63M$5.06M$4.14M$5.52M$6.43M$4.88M$8.23M$18.38M$16.37M$9.44M$11.55M
Free cash flow$-32428.00$-325250.00$-2.48M$-2.80M$-4.60M$-3.80M$-1.69M$-777573.00$-2.66M$-4.23M$-9.24M$-9.02M$-12.58M$-18.53M$-21.29M$-30.38M$-24.24M$-27.79M$-30.81M$-39.04M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-129967.00$333712.00$6.92M$8.03M$-6.10M$18.25M$-4.51M$-745008.00$7.06M$122.86M$-2.95M